Gaois

Téarmaí cosúla:

Cóip statach de shonraí a easpórtáiltear ó IATE ó am go chéile atá sa chnuasach seo. Níor cheart glacadh leis gurb ionann i gcónaí an t-eolas a thugtar faoi iontráil anseo agus a bhfuil sa leagan reatha den iontráil ar IATE. Is féidir an leagan reatha sin a cheadú ach cliceáil ar an nasc atá ar thaobh na láimhe deise ag barr gach iontrála. Breis eolais »

2 thoradh

  1. SOCIAL QUESTIONS|health|medical science

    #616814

    IATE #1032032
    sprioceistearáis néarapaite Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    NTE | neuropathy target esterase
    en
    Sainmhíniú integral membrane protein present in all neurons and in some non-neural-cell types of vertebrates involved in a cell-signalling pathway controlling interactions between neurons and accessory glial cells in the developing nervous system Tagairt "Paul GLYNN. Neuropathy target esterase. Biochem. J. (1999) 344, 625-631 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1220683/pdf/10585848.pdf [18.2.2011]"
    estérase caractéristique des neuropathies
    fr
  2. SOCIAL QUESTIONS|health|pharmaceutical industry

    #668930

    IATE #3639137
    eintiteas teiripeach nua Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Nóta <<<_not_supplied_>>>
    neuer therapeutischer Wirkstoff
    de
    new therapeutic entity | NTE
    en
    Sainmhíniú medicinal product that addresses an unmet patient need and is based on a known molecule, is formulated or used in a novel way, and has shorter development timelines and lower costs Tagairt "COM-Terminology Coordination, based on: Fereshteh Barei, Malcolm Ross. 'The refinement of the super generic concept: semantic challenge for product re-innovation?' (23.3.2023) GaBI Journal. Volume 4 | 2015 | Issue 1"
    nouvelle entité thérapeutique
    fr
    Sainmhíniú médicament répondant à un besoin non satisfait des patients, aux coûts et aux délais de développement réduits, formulé ou employé d’une manière innovante à partir d’une molécule connue Tagairt "COM-FR, d'après le site GaBiJournal - Generics and Biosimilars Initiative Journal > The refinement of the super generic concept: semantic challenge for product re-innovation? (31.5.2023) Fereshteh Barei, Malcolm Ross, (2015), Volume 4, Issue 1 (uniquement en anglais)"